Detalhe da pesquisa
1.
Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass index.
PLoS Genet
; 18(4): e1010093, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381001
2.
Small-molecule WNK inhibition regulates cardiovascular and renal function.
Nat Chem Biol
; 12(11): 896-898, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595330
3.
Sensory ataxia and cardiac hypertrophy caused by neurovascular oxidative stress in chemogenetic transgenic mouse lines.
Nat Commun
; 14(1): 3094, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248315
4.
Identification of a PCSK9-LDLR disruptor peptide with in vivo function.
Cell Chem Biol
; 29(2): 249-258.e5, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547225
5.
FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction.
Endocrinology
; 162(9)2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951176
6.
Characterization of recombinant human acetyl-CoA carboxylase-2 steady-state kinetics.
Biochim Biophys Acta
; 1794(6): 961-7, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19236960
7.
Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys.
Endocrinology
; 151(7): 3115-24, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20484464
8.
Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes.
J Med Chem
; 52(19): 6142-52, 2009 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-19746978